Aspen agrees to sell Nutritionals to Lactalis

17 September 2018 - Deborah Wilkes

Premium

South African pharmaceutical company Aspen has agreed to divest its Nutritionals business to France's Lactalis for ZAR12.9 billion (USD877 million) in cash.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: